Munchkin Man
EOG Dedicated
Re: EOG's investment advice thread.
Greetings Jimmy Hoffa:
Here is an emerging biopharmaceutical stock you might want to look at:
NAME OF COMPANY:
Mannkind Corporation
COMPANY WEB SITE LINK:
http://www.mannkindcorp.com/
TICKER SYMBOL:
MNKD
EXCHANGE
Nasdaq
On the date of Friday, May 21st, this stock closed out a price of $4.95 per share, which is very close to its 52-week low of $4.82 per share, which was reached on the very same date as the above, before the late market rally on Friday.
Its 52-week high was set on the date of September 22, 2009, at a price of $12.30 per share.
Although some forecasters are predicting a continued downward trend for this stock, the Munchkin Man is thinking about taking a small position in this stock when the market opens tomorrow (Monday) morning.
The company is currently trying to seek FDA approval for Afrezza, a new drug treatment for diabetes.
http://www.tradesignalonline.com/Markets/Story.aspx?id=587634&cat=3
Given the rising epidemic of diabetes, this stock could soar if this drug is eventually approved.
Of course, investing in this stock is pure speculation, if and until is is approved.
This is why the Munchkin Man is thinking about staking an initial position in this stock tomorrow morning.
The Munchkin Man thinks the potential is there and that this one is worth a gamble.
As always, the Munchkin Man advises any and all prospective investors to conduct their due diligence, and reach their own conclusions, before investing in this or any other stock.
Good luck!
Best Wishes,
Munchkin Man
P.S. -- STEM dipped below $1.00 per share last week and closed out Friday, March 21st, at a price of $0.99 per share.
Greetings Jimmy Hoffa:
Here is an emerging biopharmaceutical stock you might want to look at:
NAME OF COMPANY:
Mannkind Corporation
COMPANY WEB SITE LINK:
http://www.mannkindcorp.com/
TICKER SYMBOL:
MNKD
EXCHANGE
Nasdaq
On the date of Friday, May 21st, this stock closed out a price of $4.95 per share, which is very close to its 52-week low of $4.82 per share, which was reached on the very same date as the above, before the late market rally on Friday.
Its 52-week high was set on the date of September 22, 2009, at a price of $12.30 per share.
Although some forecasters are predicting a continued downward trend for this stock, the Munchkin Man is thinking about taking a small position in this stock when the market opens tomorrow (Monday) morning.
The company is currently trying to seek FDA approval for Afrezza, a new drug treatment for diabetes.
http://www.tradesignalonline.com/Markets/Story.aspx?id=587634&cat=3
Given the rising epidemic of diabetes, this stock could soar if this drug is eventually approved.
Of course, investing in this stock is pure speculation, if and until is is approved.
This is why the Munchkin Man is thinking about staking an initial position in this stock tomorrow morning.
The Munchkin Man thinks the potential is there and that this one is worth a gamble.
As always, the Munchkin Man advises any and all prospective investors to conduct their due diligence, and reach their own conclusions, before investing in this or any other stock.
Good luck!
Best Wishes,
Munchkin Man
P.S. -- STEM dipped below $1.00 per share last week and closed out Friday, March 21st, at a price of $0.99 per share.
